CD8A and neoplasm: An increasing trend with advanced tumor stage and the percentages of CD8+ HLA‐DR/CD8+ T cells (F = 4.838, P = .001, Figure 2D) and CD8+ CD38+/CD8+ T cells (F = 5.984, P < .001, Figure 2E) was shown in this study.